Edition:
United States

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

10.18USD
3:59pm EST
Change (% chg)

$0.13 (+1.29%)
Prev Close
$10.05
Open
$10.10
Day's High
$10.50
Day's Low
$10.10
Volume
63,002
Avg. Vol
103,601
52-wk High
$24.35
52-wk Low
$6.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.523
Mar '17 1.10 -0.492
FY 2016 Dec '16 0.32 -0.200
Sep '16 0.00 -0.649
Jun '16 0.00 -0.608
Mar '16 0.00 -0.542
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 3.16 10.00 0.00 --
Quarter Ending Jun-18 4 0.03 0.12 0.00 --
Year Ending Dec-18 6 2.17 10.00 0.00 19.91
Earnings (per share)
Quarter Ending Mar-18 4 -0.45 -0.16 -0.59 --
Quarter Ending Jun-18 4 -0.63 -0.55 -0.72 --
Year Ending Dec-18 6 -2.52 -2.00 -2.99 -4.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.23 35.64
P/E High - Last 5 Yrs. -- 41.43 46.80
P/E Low - Last 5 Yrs. -- 23.37 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) 186.37 6.23 8.67
Price to Book (MRQ) 3.36 4.34 5.21
Price to Tangible Book (MRQ) 3.36 4.82 6.35
Price to Cash Flow (TTM) -- 23.04 26.03
% Owned Institutions 64.22 1.25 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.24
Payout Ratio(TTM) -- 45.32 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.65 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 6.38 7.55
Sales - 5 Yr. Growth Rate -- 9.89 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.90 14.70 16.86
EPS (TTM) vs TTM 1 Yr. Ago 25.05 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.51
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.42
Current Ratio (MRQ) 9.00 3.34 3.38
LT Debt to Equity (MRQ) 0.01 9.17 12.01
Total Debt to Equity (MRQ) 0.12 12.36 15.38
Interest Coverage (TTM) -- 45.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.23 54.84
Gross Margin - 5 Yr. Avg. -- 52.57 52.61
EBITD Margin (TTM) -3,436.95 -- --
EBITD - 5 Yr. Avg -- 18.47 9.77
Operating Margin (TTM) -3,540.97 11.50 2.53
Operating Margin - 5 Yr. Avg. -- 14.27 5.00
Pre-Tax Margin (TTM) -3,503.03 11.87 3.34
Pre-Tax Margin - 5 Yr. Avg. -- 14.55 5.26
Net Profit Margin (TTM) -3,503.03 8.24 -0.18
Net Profit Margin - 5 Yr. Avg. -- 10.88 1.54
Effective Tax Rate (TTM) -- 22.44 22.12
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,782 922,196,718 822,216,427
Net Income/Employee (TTM) -903,145 107,909,384 96,151,835
Receivable Turnover (TTM) -- 5.30 5.40
Inventory Turnover (TTM) -- 2.60 3.51
Asset Turnover (TTM) 0.01 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.54 11.13 10.70
Return on Assets - 5 Yr. Avg. -- 12.64 12.00
Return on Investment (TTM) -57.93 14.02 13.57
Return on Investment - 5 Yr. Avg. -- 16.55 15.72
Return on Equity (TTM) -58.66 15.49 15.19
Return on Equity - 5 Yr. Avg. -- 17.63 16.94
  1 Year 3 Year 5 Year
Sales % 0.00 -- --
EPS (TTM) % -165.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syros Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.13 -5.02 99 53
13 Week -24.44 -27.70 22 40
26 Week -49.04 -53.99 13 20
52 Week -8.88 -21.13 99 28
YTD 3.29 1.67 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.22%
# of Holders: 95
Total Shares Held: 20,672,601
3 Mo. Net Change: 661,390
# New Positions: 20
# Closed Positions: 19
# Increased Positions: 51
# Reduced Positions: 40
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.